Last updated 17 days ago
A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Patients With High-Risk Muscle-Invasive Bladder Cancer Who Are ctDNA Positive Following Cystectomy
800 patients around the world
Available in Argentina, United States, Brazil, Spain
Hoffmann-La Roche
19Research sites
800Patients around the world
This study is for people with
Bladder Cancer
Muscle-Invasive Bladder Cancer
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Av. Galvan 4102, CABA, Buenos Aireswww.cemic.edu.ar/
Av. Crámer 1180, CABA, Buenos Aires
Montevideo 955, C1019ABS Cdad. Autónoma de Buenos Aires, Argentina
Av. do Contorno, 3800 - Santa Efigênia, Belo Horizonte - MG, 38082-049, Brazil
Av. Pres. Vargas, 2355 - 913 - Nossa Sra. de Fátima, Santa Maria - RS, 97015-513, Brazil
Av. Dr. Arnaldo, 251 - Consolação, São Paulo - SP, 01255-090, Brazil
R. Maestro Cardim, 637 - Bela Vista, São Paulo - SP, 01323-001
R. Ramiro Barcelos, 910 - Floresta, Porto Alegre - RS, 90035-001, Brazil
Av. Ipiranga, 6690 - 4º andar - Partenon, Porto Alegre - RS, 90610-001, Brazil
655 Rio Itacorubi Florianópolis SC BR 88034-000, Rod. Admar Gonzaga - Itacorubi, Florianópolis - SC
R. Doná Silvéria, 150 - Chácara Braz Miraglia, Jaú - SP, 17210-080, Brazil
Av. Pontes Vieira, 2571 - Dionísio Torres, Fortaleza - CE, 60135-237
Av. Francisco Trein, 596 – 2º andar - Bairro: Cristo Redentor - CEP 91350-200 - Porto Alegre
R. Treze de Maio, 1815 - Bela Vista, São Paulo - SP, 01323-020, Brazil
Rua Antenor Duarte Villela 1331 - Barretos, Sao Paulo, 14784-400
StudyIMvigor011
SponsorHoffmann-La Roche
Study typeInterventional
Conditions
Muscle-Invasive Bladder Cancer
Requirements
From 18 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT04660344
